BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 26679838)

  • 1. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
    Hu C; Li L
    Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
    Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of reprogramming technology for cancer research].
    Yagi M; Semi K; Yamada Y
    Nihon Rinsho; 2015 May; 73(5):751-5. PubMed ID: 25985626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.
    Kwon D; Kim JS; Cha BH; Park KS; Han I; Park KS; Bae H; Han MK; Kim KS; Lee SH
    Cell Transplant; 2016; 25(6):1025-42. PubMed ID: 26450367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental approaches for the generation of induced pluripotent stem cells.
    Sommer CA; Mostoslavsky G
    Stem Cell Res Ther; 2010 Aug; 1(3):26. PubMed ID: 20699015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleurotus eryngii Polysaccharide Promotes Pluripotent Reprogramming via Facilitating Epigenetic Modification.
    Deng W; Cao X; Wang Y; Yu Q; Zhang Z; Qu R; Chen J; Shao G; Gao X; Xu X; Yu J
    J Agric Food Chem; 2016 Feb; 64(6):1264-73. PubMed ID: 26809505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.
    Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD
    Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine.
    Revilla A; González C; Iriondo A; Fernández B; Prieto C; Marín C; Liste I
    J Tissue Eng Regen Med; 2016 Nov; 10(11):893-907. PubMed ID: 25758460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
    Quintana-Bustamante O; Segovia JC
    Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of induced pluripotent stem cells from somatic cells.
    Sohn YD; Han JW; Yoon YS
    Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Footprint-Free Induced Pluripotent Stem Cells from Human Fibroblasts Using Episomal Plasmid Vectors.
    Ovchinnikov DA; Sun J; Wolvetang EJ
    Methods Mol Biol; 2015; 1330():37-45. PubMed ID: 26621587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The piggyBac Transposon as a Platform Technology for Somatic Cell Reprogramming Studies in Mouse.
    Woltjen K; Kim SI; Nagy A
    Methods Mol Biol; 2016; 1357():1-22. PubMed ID: 26126450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming of Human Fibroblasts with Non-integrating RNA Virus on Feeder-Free or Xeno-Free Conditions.
    Lieu PT
    Methods Mol Biol; 2015; 1330():47-54. PubMed ID: 26621588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.